4.5 Article

Intellectual property protection Strategies for future antibody inventions

Journal

MABS
Volume 3, Issue 3, Pages 310-317

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/mabs.3.3.15530

Keywords

antibody; mimetics; patent; inventive; intellectual property

Ask authors/readers for more resources

In the last decade, therapeutic antibodies have become one of the most commercially successful classes of bio-pharmaceutic drugs. Major drug manufacturers who have successfully managed to occupy this new market, as well as biotechnology firms, some of which have experienced a quick growth and are now on par with the former, owe part of their success to suitable intellectual property (IP) strategies. This article provides an overview of the current thinking on antibody-related patents, and discusses strategies for protecting the antibody products of the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available